Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CLONIDINE HYDROCHLORIDE CRS (25 MG)

CLONIDINE HYDROCHLORIDE CRS (25 MG)

4205-91-8

DISCOVER
CLOSTRIDIA (MULTI-COMPONENT) RABBIT ANTISERUM(FOR VACCINES-V

CLOSTRIDIA (MULTI-COMPONENT) RABBIT ANTISERUM(FOR VACCINES-V

NA

DISCOVER
CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - VET.

CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - VET.

NA

DISCOVER
CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - HUMA

CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - HUMA

NA

DISCOVER
CLOSTRIDIUM TETANI RABBIT ANTISERUM (FOR VACCINES - VET. USE

CLOSTRIDIUM TETANI RABBIT ANTISERUM (FOR VACCINES - VET. USE

NA

DISCOVER
(-)-Cotinine

(-)-Cotinine

486-56-6

DISCOVER
CLOTRIMAZOLE CRS (100 MG)

CLOTRIMAZOLE CRS (100 MG)

23593-75-1

DISCOVER
CLOXACILLIN SODIUM CRS (230 MG)

CLOXACILLIN SODIUM CRS (230 MG)

7081-44-9

DISCOVER
CLOZAPINE CRS (60 MG)

CLOZAPINE CRS (60 MG)

5786-21-0

DISCOVER
COCOYL CAPRYLOCAPRATE  CRS (40 MG)

COCOYL CAPRYLOCAPRATE CRS (40 MG)

NA

DISCOVER
Codeine - reference spectrum,Qty : n/a

Codeine - reference spectrum,Qty : n/a

NA

DISCOVER
Codeine hydrochloride dihydrate - reference spectrum, Qty :n/a

Codeine hydrochloride dihydrate - reference spectrum, Qty :n/a

NA

DISCOVER